Effect of early intrajejunal nutrition on pancreatic pathological features and gut barrier function in dogs with acute pancreatitis.
BACKGROUND
In patients with major trauma and burns, total enteral nutrition (TEN) significantly decreases the acute phase response and incidence of septic complications when compared with total parenteral nutrition (TPN). Traditionally, it was believed that early intrajejunal nutrition (EIN) in severe acute pancreatitis (SAP) may exacerbate the clinical pathological features, lead to recurrence of symptoms and delay complications.


OBJECTIVE
To compare the effect of EIN vs TPN on the pancreatic pathological features and gut barrier function in dogs with acute pancreatitis (AP).


METHODS
Fifteen dogs (surviving over 7 days, the death rate being 32%, 7/22) were divided into parenteral nutrition (PN) group (n=7) and EIN group (n=8). SAP model was induced by injecting 1 ml/kg of combined solution of 2.5% sodium taurocholate and 8000-10000 BAEE units trypsin/ml into the pancreas via the pancreatic duct. Nutrients were delivered to the EIN group by catheter via a jejunostomy feeding 24 h postoperatively. The two groups were isocaloric and isonitrogenous. Systemic blood samples were obtained before and 1, 4, 7 d following AP, and cultured by aerobic as well as anaerobic bacterial growth. Systemic plasma and portal vein endotoxin levels were quantified by the chromogenic limulus amebocyte lysate (LAL) technique. Portal vein blood and specimens of tissue from mesenteriolum and mesocolon lymph nodes, lung, pulmonary portal lymph nodes and pancreas were adopted before the experiment was finished. Aliquots of the homogenata were cultured as blood mentioned above. Serum glucose, calcium, amylase and lysosomal enzymes were determined. All dogs were injected with 50 microCi (125)I-BSA 4 h at the 7th day before being sacrificed. The (125)I-BSA indexes of the pancreas/muscle and pancreas/blood were measured, and pancreatitic pathological scores (PPSs) of the different partial pancreas were observed. The content of mucosa protein, DNA and the villi, the thickness of mucosa and the whole bowel wall of the ileum and transverse colon were measured.


RESULTS
The study showed that serum glucose in the PN group was higher than in the EIN group after SAP 3 d; the levels of systemic plasma endotoxin and the magnitude of bacterial translocation to the portal and systemic blood and distant organ reduced significantly in the EIN group P<0.01. There were no differences between the two groups in the data of serum calcium, amylase and lysosomal enzymes, P>0.05; the (125)I-BSA index of pancreas/muscle and pancreas/blood, and PPS of the head, body, tail and total pancreas did not reach significant difference between the two groups, P>0.05. The contents of protein and DNA, the height of villi, the thickness of mucosa and the whole bowel wall of the ileum and transverse colon in the EIN group were higher than that in the PN group,P <0.01.


CONCLUSIONS
Our results suggested that EIN was safe and effective to be adopted by intrajejunal delivery of nutrients in SAP dogs, did not make SAP clinical pathological features deteriorate, and decreased the occurrence rate of endotoxin and gut bacterial translocation.
Qin
H-L
HL
Department of Surgery, Shanghai Sixth People's Hospital, Shanghai, Peoples Republic of China.
Su
Z-D
ZD
Hu
L-G
LG
Ding
Z-X
ZX
Lin
Q-T I
QT
D000208:Acute Disease; D000681:Amylases / Q000097:blood; D000818:Animals; D018988:Bacterial Translocation / Q000502:physiology*; D001786:Blood Glucose / Q000032:analysis; D002118:Calcium / Q000097:blood; D003106:Colon / Q000382:microbiology / Q000473:pathology; D004247:DNA / Q000378:metabolism; D004195:Disease Models, Animal; D004285:Dogs; D004731:Endotoxins / Q000097:blood; D004750:Enteral Nutrition / Q000379:methods; D007082:Ileum / Q000382:microbiology / Q000473:pathology; D007582:Jejunostomy; D010179:Pancreas / Q000473:pathology*; D010195:Pancreatitis / Q000382:microbiology / Q000473:pathology / Q000628:therapy*; D010289:Parenteral Nutrition, Total; D011897:Random Allocation; D012449:Safety; D016896:Treatment Outcome
D001786:Blood Glucose; D004731:Endotoxins; D004247:DNA; D000681:Amylases; D002118:Calcium